RosVivo Therapeutics targets diseases with breakthrough therapies utilizing microRNA (miRNA) and small interfering-RNA (siRNA) drugs. They're using unique scientific insights to develop a new pipeline of first-in-class drugs and diagnostic tests. Their development programs focus on the leading T2D, obesity, and COVID-19 drug candidates.

Biotechnology

RosVivo Therapeutics

RosVivo Therapeutics' headquarters in Reno, NV, United States

This department oversees strategic direction and decision-making across the organization.

Leadership Council

The Research and Advisory Team at RosVivo Therapeutics conducts cutting-edge scientific research to advance miRNA and siRNA therapies, focusing on type 2 diabetes, obesity, and COVID-19. The team leverages unique insights to drive the development of novel drug candidates and diagnostic tests while providing strategic direction and expert consultation to guide the company's therapeutic pipeline.

Research and Advisory Team

The Leadership Team at RosVivo Therapeutics is responsible for guiding the company's strategic vision and operational execution in the development of innovative therapies targeting diseases through cutting-edge microRNA and siRNA technologies. Comprising the CEO, co-founders, and key scientific leaders, the team collaborates to oversee research initiatives, ensure regulatory compliance, secure funding, and drive the advancement of first-in-class drug and diagnostic test pipelines focusing on T2D, obesity, and COVID-19.

��

People (3)

Jobs (0)

Other teams

Research and Advisory Team

Leadership Team

��������

People (3)

Jobs (0)

Other teams

Research and Advisory Team

Leadership Team

��